The global blood warmer devices market size was valued at USD 1.31 billion in 2025 and is projected to grow from USD 1.40 billion in 2026 to USD 2.42 billion by 2034, registering a CAGR of 7.08% during the forecast period (2026-2034). North America dominated the blood warmer devices market with a share of 43.61% in 2025.
Blood warmer devices are medical equipment designed to heat blood and intravenous fluids to a controlled temperature before administration to patients. These devices help prevent hypothermia during blood transfusions and emergency treatments. They are widely used in hospitals, emergency departments, and intensive care units. Blood warmer devices are classified under HSN Code 9018.90 (other medical and surgical instruments and appliances) and SIC Code 3841 (surgical and medical instruments and apparatus).
The blood warmer devices market demand is driven by rising blood transfusion requirements, and the adoption of temperature management systems. Advancements in portable warming devices and expanding healthcare infrastructure contribute to blood warmer devices market growth.
Download a Free Sample To learn more about this report,
Shift Toward Portable Blood Warming Systems for Prehospital Care
The blood warmer devices market analysis indicates a shift from conventional hospital based equipment toward portable warming systems. Emergency medical teams are adopting compact, battery-operated devices for blood transfusions during patient transportation. Portable systems are becoming an important part of emergency transfusion equipment across ambulance and military medical services.
Integration of Air Detection and Temperature Control Technologies
Blood warmer devices are evolving toward integrated safety systems that combine controlled heating with air detection and automated monitoring. This transition is changing device designs from basic fluid-heating equipment to advanced transfusion management systems. For example, TSC Life's Fluido AirGuard system combines blood and fluid warming with enhanced patient safety features for high-flow applications.
Supply chain disruptions are expected to have a moderate impact on the blood warmer devices market share due to shortages of electronic components, heating elements, medical-grade plastics, and disposable tubing. The market is expected to experience a K-shaped recovery, as established manufacturers can restore production faster than smaller suppliers. The market is projected to grow at a CAGR of 7.08%. Supply constraints could temporarily reduce this by an estimated 1.5 percentage points, resulting in a growth of 5.58%. Improved component availability, stable transportation costs, and normalized manufacturing operations are expected to support a gradual recovery toward the projected CAGR of 7.08%.
In April 2026, India's Ministry of Health and Family Welfare awarded a procurement bid for 13 blood and fluid warmers, with a reported bid value of approximately USD 8,900. Indian Surgical Equipment Company Private Limited was identified as the winner. In May 2026, the same ministry's procurement process covered 25 blood and fluid warmers, with a reported bid value of approximately USD 6,900. Acer Biomedicals LLP was identified as the winning supplier.
Use of Therapeutic Plasma Exchange and Increasing Emphasis on Perioperative Hypothermia Prevention Drive Market
The use of therapeutic plasma exchange for autoimmune, neurological, and hematological disorders is creating specialized demand for blood warmer devices. During apheresis procedures, blood and replacement fluids circulate outside the body, increasing the risk of unintended cooling, especially among pediatric patients. Clinical guidelines recommend warming extracorporeal blood and replacement solutions, encouraging hospitals to adopt compatible warming systems with precise temperature control and monitoring capabilities.
Emphasis on preventing perioperative hypothermia is strengthening demand for blood warmer devices in surgical care. Hospitals are adopting fluid warming practices to maintain stable patient temperatures during procedures. The UK's National Institute for Health and Care Excellence (NICE) recommends warming intravenous fluids of 500 mL or more and blood products to 37°C during surgery. Such clinical recommendations support the integration of blood warming devices into operating rooms and perioperative care protocols.
High Disposable Consumable Costs and Temperature Performance Limitations at High Flow Rates Restrict Market Growth
Blood warmer devices require dedicated single use tubing sets for each transfusion procedure. These consumables create recurring expenses beyond the initial equipment purchase. Hospitals must also maintain compatible supplies to ensure uninterrupted operation. The additional operating costs can limit device adoption in smaller healthcare facilities with restricted budgets. Dependence on manufacturer-specific consumables further reduces purchasing flexibility and increases the overall cost of blood warming procedures.
Blood warmer devices face performance limitations when blood is administered at high flow rates. Inadequate heating can result in lower-than-required transfusion temperatures and increase the risk of patient hypothermia. The U.S. FDA has documented discrepancies between advertised and actual heating performance in certain blood warming systems.
Preference for Low-Priming-Volume Blood Warmers and Emergence of Systems for Neonatal Exchange Transfusions Offer Growth Opportunities
Precise transfusion management in neonatal intensive care units is creating opportunities for low-priming-volume blood warmer devices. Newborns receive smaller blood volumes, requiring systems that minimize fluid retention while maintaining controlled temperatures. For example, AirLife’s enFlow Fluid and Blood Warming System uses a disposable cartridge requiring less than 4 mL of priming volume. Such innovations offer manufacturers opportunities to develop specialized neonatal warming solutions.
Newborns are vulnerable to temperature fluctuations during transfusion procedures. Manufacturers can develop low-flow warming systems with reduced priming volumes for neonatal care. For example, Indian government medical equipment specifications identify blood warmers with a priming volume below 5 mL and flow rates of 5–80 mL/min. Such specifications highlight opportunities for neonatal specific warming technologies.
Intravenous in-line dominated the product type segment with a share of 48.36% in 2025. This dominance is led by the utilization of continuous blood warming during surgical transfusions and the preference for direct warming across hospital transfusion procedures.
The surface/convective fluid segment is expected to achieve a growth rate of 7.18% during the forecast period, driven by the preference for non-contact heating mechanisms and utilization of reusable heating platforms.
Request Customizationto receive a tailored report.
Portable is likely to witness a CAGR of 8.14% during the forecast period. This growth is driven by expanding prehospital blood transfusion services and demand for battery-operated systems in air ambulances.
Stationary segment is projected to reach a CAGR of 5.72% during the forecast period due to expanding utilization of fixed blood warming equipment in surgical departments.
Surgery & peri-operative care dominated the application segment with a share of 45.28% in 2025, owing to increasing emphasis on preventing perioperative hypothermia. Wider implementation of surgical temperature management protocols is supporting routine blood warmer utilization during major operations.
Critical care is expected to experience a growth rate of 7.58% during the forecast period. This growth is driven by the use of rapid transfusion protocols in trauma resuscitation and emphasis on preventing transfusion-related hypothermia.
Hospitals led the end use segment, accounting for a share of 6.84% in 2025. Hospitals are equipped with dedicated blood banks and advanced transfusion facilities. Higher patient admission volumes and the availability of specialized surgical units support greater utilization of blood warmer devices.
The defense forces segment is projected to undergo growth at a CAGR of 8.36% during the forecast period, driven by investments in military medical equipment and deployment of field transfusion units to support blood warmer device adoption.
Speak to an Analystto discuss market opportunities.
The North America blood warmer devices market accounted for the largest regional share of 53.80% in 2025.
U.S. Blood Warmer Devices Market
Agency for Healthcare Research and Quality (AHRQ) identifies the maintenance of normal body temperature as an important measure for preventing surgical complications. Its perioperative infection prevention resources include recommendations for monitoring patient temperature during surgery. These clinical practices are expected to support demand for blood and intravenous fluid warming devices across surgical facilities.
Canada Blood Warmer Devices Market
Public Health Agency of Canada's Transfusion Transmitted Injuries Surveillance System monitors more than 95% of blood transfusion activities nationwide. Its surveillance findings help hospitals evaluate transfusion practices and improve clinical safety. These measures are expected to support the adoption of specialized blood warming equipment during rapid transfusions and critical care procedures.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific blood warmer devices market is expected to grow at a CAGR of 5.20% during the forecast period, showcasing the fastest-growing regional market.
China Blood Warmer Devices Market
China's National Health Commission identifies hypothermia as a complication associated with rapid administration of large volumes of cold blood components. Its technical guidance highlights the importance of recognizing temperature-related transfusion risks. This clinical emphasis is expected to create opportunities for blood warming equipment in emergency and high-volume transfusion settings.
India Blood Warmer Devices Market
The Ministry of Health and Family Welfare's clinical establishment standards specify blood warming during rapid transfusions and neonatal exchange transfusions. The standards also recommend dedicated warming devices with temperature monitoring capabilities. These requirements are expected to support demand for compliant blood warmer equipment in hospital blood transfusion services.
Japan Blood Warmer Devices Market
Japan is expected to benefit from established transfusion management practices and specialized treatment requirements. Its clinical guidance also identifies efficient warming systems for preventing hypothermia during substantial blood loss. These requirements are expected to support blood warmer device utilization in specialized hospital departments.
The Europe blood warmer devices market is estimated to achieve 4.60% CAGR during the forecast period.
UK has an extensive network of NHS hospitals that caters to the need for advanced transfusion support in emergency care. The availability of specialized trauma centers and established blood transfusion services supports the use of blood warming equipment during critical procedures. Emphasis on reducing transfusion-related complications and improving emergency treatment capabilities is expected to strengthen blood warmer device adoption across public healthcare facilities.
German Association of Scientific Medical Societies recommends supplementary intravenous fluid warming during operations involving infusion rates above 500 mL per hour. Its clinical guidance also identifies in-line warming as a preferred approach. These recommendations are expected to support the utilization of blood warmer devices in surgical departments managing substantial fluid administration.
The Latin America blood warmer devices market will expand to 5.50% CAGR during the forecast period. Brazil's Ministry of Health specifies that blood warming, when clinically indicated, must be performed using dedicated equipment with visible temperature monitoring and audible or visual alarms.
Mexico's regulation permits controlled blood warming during transfusions at flow rates of 15 mL/min or higher and specifies equipment with temperature monitoring and alarm systems. These requirements are expected to support the adoption of compliant blood warming systems across specialized transfusion services.
The Middle East & Africa blood warmer devices market is anticipated to grow at a CAGR of 4.08% during the forecast period. South Africa's National Department of Health recommends the use of approved and validated warming devices during massive transfusions in maternal care to prevent hypothermia. This recommendation supports the use of specialized blood warming equipment in obstetric emergency services.
UAE also has specific requirements for blood warming during transfusion procedures. UAE federal blood transfusion regulations advise using blood warmers when large blood volumes must be administered rapidly to reduce temperature-related complications.
The blood warmer devices market competitive landscape is fragmented, encompassing multinational medical technology companies, specialized manufacturers, and regional suppliers. Key participants such as Solventum, ICU Medical, Stryker, Baxter, and GE HealthCare are estimated to account for over 30% of the global blood warmer devices market share.
Established companies compete through clinical reliability, temperature accuracy, and disposable consumables. Emerging and regional players in the blood warmer devices market ecosystem compete through portable rapid warming systems, battery-powered operation, and distribution partnerships.
September 2026: QinFlow launched PressSure, a battery-powered infusion pressure management device designed to maintain consistent pressure during blood and IV fluid administration.
June 2026: Belmont Medical Technologies completed its acquisition of Arcos, Inc., expanding its critical care portfolio with Burn Navigator and BloodNav solutions for burn management and transfusion workflows.
April 2026: MEQU received U.S. FDA 510(k) clearance for its °M Warmer System with °M Station, enabling continuous blood and IV fluid warming during patient transfers from prehospital to hospital settings.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Experts
The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.
The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.
Cranial And Facial Implants Market Size, Forecast, Demand, Opportunities, 2034
Arthroscopy Devices Market Size, Forecast, Opportunities, 2034
Ablation Devices Market Size, Forecast, Demand, Opportunities, 2034
Coronary Guidewires Market Size, Forecast, Demand, Opportunities, 2034
Coagulation Analyzers Market Size, Forecast, Demand, Opportunities, 2034
Centesis Catheters Market Size, Forecast, Opportunities, 2034
We are featured on:
sales@straitsresearch.com